Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
Zver
Samo
S
Andoljsek
Dusan
D
Cernelc
Peter
P
D000328:Adult; D002405:Catheterization, Central Venous / Q000009:adverse effects; D016638:Critical Illness; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D005260:Female; D005263:Femoral Artery / Q000293:injuries; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000188:drug therapy; D011994:Recombinant Proteins / Q000627:therapeutic use*; D065227:Transfusion Reaction; D014212:Tretinoin / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; D014212:Tretinoin; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa